Sesbania

Sesbania: A Comprehensive Reference

1. Identity: Botanical Classification, Natural Sources, and Common Forms

Taxonomy and Botanical Classification

Sesbania is a genus of flowering plants in the pea family, Fabaceae, and the only genus found in the tribe Sesbanieae. The genus was formally described by Scopoli in his Introductio ad Historiam Naturalem (1777) and is classified within the kingdom Plantae, phylum Tracheophyta, class Magnoliopsida, and order Fabales. Some 60 species are currently accepted. The genus is native to tropical and subtropical regions around the world, in the Americas from the southern United States to northern Argentina, in sub-Saharan Africa, in southern Asia, and in New Guinea, Australia, and the Pacific.

Three species are of predominant medicinal and dietary significance:

• Sesbania sesban (L.) Merr. — the Egyptian riverhemp, a species of plant in the legume family, a fast-growing species with four currently recognized varieties.
• Sesbania grandiflora (L.) Pers. — a small, erect, fast-growing, and sparsely branched tree belonging to the Leguminosae family, commonly known as agathi, agase, or the hummingbird tree.
• Sesbania cannabina (Retz.) Poir. — spiny sesbania, also documented for bioactive constituents.

A comprehensive review of the genus evaluates three species in particular: Sesbania sesban, Sesbania grandiflora, and Sesbania cannabina.

Morphological Description

S. sesban is a perennial shrub or small tree that grows up to 6 m tall, sometimes reaching 8 m. It has paripinnately compound leaves with between 6–27 pairs of linear to oblong leaflets per pinnae; the leaves and rachis tend to be pilose. Flowers are yellow in color with brown and purple streaks on the corolla. Sesbania sesban occurs widely in tropical East and West Africa, in Southern Africa, and in Asia.

Agasti (S. grandiflora) is a small, fast-growing deciduous tree reaching 10–15 m, with pinnate leaves and drooping clusters of fragrant flowers. The blossoms can be milky-white, blush-pink, or deep crimson. Its seed pods are bean-like, long and slender, and are often eaten as a vegetable.

Natural Range

The native range of S. sesban spans tropical and southern Africa, the Arabian Peninsula, and the Indian Subcontinent. It is a shrub or tree growing primarily in the seasonally dry tropical biome. The largest number of Sesbania species are found in Africa, and the remainder in Australia, Hawaii, and Asia.

Common Forms and Preparations

The various plant parts are used in different dosage forms such as paste, cream, powder, tablets, capsules, tincture, extracts, and tonic. Different parts of the plant — leaves, seed, and pods — are reputed for their medicinal value. Agathi keerai, a south Indian dish, is prepared from the young edible leaves; delicious soups and fritters are prepared from the flowers. Leaves are also used for treating anemia and as an antidote for tobacco- and cigarette-related respiratory problems. Steamed flowers are used as a traditional Indonesian dish. Aqueous decoctions, methanolic extracts, and ethanolic extracts have been employed in most pharmacological studies, while the fresh plant parts — leaves, flowers, bark, roots, and seeds — are each associated with distinct traditional applications.

2. Traditional and Historical Use

Ayurvedic and Siddha Systems (India)

Sesbania sesban (Family: Fabaceae) is a well-known plant widely distributed in India and other tropical countries. In Ayurveda, S. grandiflora is revered under the Sanskrit name Agastya or Agathi. According to the Ayurvedic system, the root, stem, flowers, fruit, and leaves are used in body pain, boils, coryza, epilepsy, emaciation, fever, worm infection, hemorrhage, night blindness, and promoting memory. According to the Siddha system, the root, bark, leaf, and flowers are used in food poisoning, pittaja vikaras (bile-related disorders), worm infestation, intermittent fever, sinusitis headache, eye diseases, chickenpox, and wasting diseases.

This plant, native to tropical regions of Asia, particularly India, is traditionally used to treat a wide range of ailments due to its potent anti-inflammatory, diuretic, antipyretic, and digestive properties. In Ayurveda, Agastya is known to be beneficial for respiratory conditions due to its Vata and Kapha balancing properties. It helps to clear mucus from the lungs, making it useful for conditions such as asthma and bronchitis, and is often prescribed for coughs, colds, and other respiratory infections.

The leaves of Sesbania sesban have traditionally been used as purgative, demulcent, maturant, anthelmintic, and for all pains and inflammation.

Traditionally, this plant is also used in menorrhagia, spleen enlargement, diarrhea, and as anthelmintic, astringent, emmenagogue, anti-inflammatory, and for dysuria. Important Ayurvedic formulations include Ratnagiri Rasa and Mahapaisachikaghritam.

African Traditional Medicine

Local inhabitants in Chad use the species as medicine, livestock feed, and fuelwood, and for improving soil fertility and repelling desert encroachment. Traditional healers use its leaves to treat breast cancer and edema. It has numerous medicinal uses, mostly recorded in Africa and Asia. Seeds are useful for diarrhea, extreme menstrual flow, for the reduction of the size of an enlarged spleen, and for use in skin ailments, as well as in cases of rheumatic inflammatory swelling. For inflammatory swelling and as an anthelmintic, the consumption of leaves is indicated.

Southeast Asian and Pacific Traditional Medicine

The leaves, flowers, and seeds of S. grandiflora are widely used not only in India but in many countries of South Asia, including Sri Lanka, Thailand, Java, Khmer, Vietnam, Indonesia, Maldives, and the Philippines, in culinary preparations. Its diverse applications include use in green manure to enhance soil fertility, as a source of animal fodder, in traditional medicine for treating various ailments like cellular tissue, circulatory, immune, and sensory system disorders, and in bioremediation efforts to restore polluted environments.

Historical Record

According to ethnomedicinal claims, the poultice of leaves of S. sesban promotes suppuration of boils and abscesses and absorption of inflammatory rheumatic swellings. Juice of fresh leaves is credited with anthelmintic properties. The bark has also been reported as an astringent tonic, infusion for smallpox and other eruptive fevers, and used for the treatment of ulcers in the mouth and alimentary canal, diarrhea, dysentery, and dyspepsia. S. grandiflora leaves juice has been reported for the treatment of bronchitis, cough, vomiting, wounds, ulcers, diarrhea, and dysentery.

3. Key Phytochemical Constituents and Active Compounds

Major Compound Classes

Mainly alkaloids, carbohydrates, flavonoids, glycosides, saponins, tannins, steroids, anthraquinone, proteins, and terpenoids are present as phytochemical constituents of Sesbania grandiflora. Preliminary phytochemical screening of S. sesban leaf in three different extracts (ethanol, methanol, and aqueous extract) revealed the presence of carbohydrates, tannins, saponins, glycosides, steroids, flavonoids, phenols, terpenoids, alkaloids, and glycosides.

The plant synthesizes an array of bioactive compounds, with the highest levels of lipids and alkaloids occurring in the summer season.

Specific Isolated Compounds

Three isoflavanoids — isovestitol, medicarpin, and sativan — along with the known compound betulinic acid, have been isolated from the root of Sesbania grandiflora. Isovestitol, medicarpin, and sativan (isoflavonoids) and betulinic acid (a tannin substance) are among the major constituents responsible for antibacterial and antifungal, antioxidant, anti-urolithiatic, anticonvulsant, anxiolytic, and hepatoprotective properties.

Compounds such as quercetin, kaempferol, and sesbagrandiforian A and B have been highlighted for their strong antioxidant and antiproliferative effects. Sesbanimides derived from S. grandiflora seeds have demonstrated potent cytotoxic effects by disrupting mitochondrial function.

The spermicidal compound oleanolic acid 3-β-D-glucuronide (OAG) has been identified as an active principle isolated from root extracts of Sesbania sesban.

Previous phytochemical investigations of S. sesban led to the isolation of oleanolic acid, stigmasta-5,24(28)-diene-3-ol-3-0-β-D-galactopyranoside, fatty acids, and amino acids. Various types of lignins are composed of guaiacyl, syringyl, and p-hydroxyphenylpropane building units, and also the anti-tumor principal, kaempferol trisaccharide.

Mechanisms of Action

The phytochemicals found in Sesbania species, such as flavonoids, alkaloids, and saponins, possess unique structural features that contribute to their biological activities. Flavonoids in Sesbania exhibit strong antioxidant properties, which play a significant role in scavenging free radicals and reducing oxidative stress, a key factor in cancer progression.

Sesbania grandiflora possesses antioxidant potential, as suggested by its ability to suppress ROS generation while potentiating the upregulation of endogenous antioxidant enzymes like superoxide dismutase and catalase. In vivo experiments have shown that it can replenish the activities of important endogenous antioxidant enzymes such as glutathione peroxidase, catalase, and superoxide dismutase.

Extensive research on S. grandiflora has uncovered mechanisms such as the activation of caspase cascades and the induction of apoptosis, attributed to its rich content of flavonoids and alkaloids.

It may also improve endothelial functioning by increasing endothelial nitric oxide synthase and subsequent production of nitric oxide, a vasodilator and anti-inflammatory agent that reduces vascular inflammation.

Exposure to extracts of Sesbania grandiflora and Sesbania sesban during the inflammation process may modulate that process due to the presence of isolated triterpenoidal compounds.

4. Scientific Evidence by Area of Use

4.1 Antidiabetic Activity

Sesbania grandiflora has been traditionally used as antidiabetic, antioxidant, antipyretic, and expectorant, and in the management of various ailments.

Animal studies — S. grandiflora: One PMC-indexed study evaluated the antidiabetic activity of methanolic extract of Sesbania grandiflora (MESG) in type 2 diabetic rats induced by low-dose streptozotocin and high-fat diet. Diabetic rats were given MESG at 200 and 400 mg/kg orally, and the standard drug metformin (10 mg/kg), for 28 days. MESG at 200 and 400 mg/kg induced a significant reduction (P < 0.05) of raised blood glucose levels in diabetic rats and restored other parameters to normal. It was concluded that MESG has potential antihyperglycemic and antihyperlipemic activities and alleviates insulin resistance conditions.

A separate PMC-indexed study examined carbohydrate metabolic enzymes. That study was designed to explore the anti-hyperglycemic efficacy of Sesbania grandiflora flower (SGF) extract by evaluating C-peptide, insulin, glucose, HbA1C, hemoglobin, glycogen, and carbohydrate metabolic enzyme activities in diabetic rats. SGF treatment at 250 mg/kg body weight for 45 days lowered glucose and HbA1C while simultaneously ameliorating concentrations of C-peptide, insulin, hemoglobin, glycogen, and carbohydrate metabolic enzymes. Moreover, SGF-administered diabetic rats showed diminished food and water consumption and improved body weight.

Animal studies — S. sesban: The aqueous leaves extract of Sesbania sesban was evaluated for its antidiabetic potential on normal and streptozotocin-induced diabetic rats. In the chronic model, the aqueous extract was administered at doses of 250 and 500 mg/kg body weight per day for 30 days. The fasting blood glucose levels, serum insulin level, and biochemical data such as glycosylated hemoglobin, total cholesterol, triglycerides, HDL, and LDL were evaluated and compared to the known antidiabetic drug glibenclamide (0.25 mg/kg). Pandhare et al. (2011) demonstrated that the aqueous leaf extract possesses significant antidiabetic activity. Improved metabolic parameters — elevated body weight, liver glycogen, serum insulin, and HDL cholesterol, as well as decreased blood glucose, glycosylated hemoglobin, total cholesterol, and triglycerides — were observed. The results were similar to those of glibenclamide. Notably, normal rats were not significantly affected by the extract.

Evidence strength: Human clinical trials are scarce, with only one notable study, highlighting the need for stringent randomized controlled trials, particularly for type 2 diabetes, chronic inflammation, and traditional indications. All antidiabetic evidence as of current review is from animal (rodent) models; no peer-reviewed controlled human trials have been published.

4.2 Anti-Inflammatory and Anti-Arthritic Activity

Increased swelling of the non-injected paw (secondary paw) measured on days 14 and 21, injected paw swelling (primary paw) measured on days 3, 14, and 21, splenomegaly, thymic involution, and loss in body weight, which are features of adjuvant-induced arthritis, were effectively reduced after prophylactic administration of bark extracts of Sesbania grandiflora and Sesbania sesban in rats. The leaf of this plant has topical anti-inflammatory activity that can be attributed to a crude saponins extract.

Evidence strength: Anti-inflammatory and anti-arthritic evidence is derived from in vitro and animal studies only; no human clinical trials have been identified in the peer-reviewed literature.

4.3 Antioxidant Activity

Flower petal extract of S. sesban yields anthocyanins obtained with methanolic and acidified methanol extractions, which possess antioxidant characteristics. From the flower petals, anthocyanins have been identified as important components that possess free-radical dose-dependent activities for DPPH, hydroxyl radical, and superoxide anion.

Flavonoids and phenolic compounds in the plant have been shown to reduce oxidative stress by scavenging free radicals and preventing lipid peroxidation.

Evidence strength: Antioxidant activity is well-supported in vitro. In vivo animal data support restoration of endogenous antioxidant enzymes. No human trials on antioxidant endpoints have been reported.

4.4 Hepatoprotective Activity

Oral administration of an ethanolic extract of S. grandiflora leaves at 200 mg/kg/day for 15 days produced significant hepatoprotection against erythromycin estolate (800 mg/kg/day)-induced hepatotoxicity in rats. The increased levels of serum enzymes (AST, ALT, ALP), bilirubin, cholesterol, triglycerides, phospholipids, free fatty acids, plasma TBARS, and hydroperoxides observed in rats treated with erythromycin estolate were significantly decreased by concomitant sesbania treatment. The sesbania extract also restored the depressed levels of antioxidants to near normal. The effect of sesbania was compared with that of silymarin, a reference hepatoprotective drug.

A subsequent in vivo and in vitro study using a flavonoid-rich fraction reported: In vivo, the serum levels of SGOT, SGPT, total triglyceride, and total bilirubin were measured in experimental animals treated with the flavonoid-rich ethanolic extract. Significant reductions in the levels of hepatic injury markers were observed, indicating hepatoprotective potential. The treated groups showed significant restoration of these biomarkers. Molecular docking studies revealed the binding affinities of flavonoids for PPARα, suggesting this as a mechanistic target. These findings suggest that a promising lead candidate for the development of therapeutic medicines against anti-TB drug-induced hepatotoxicity has been identified.

The ethanolic and aqueous extract of flowers of Sesbania grandiflora also show hepatoprotective activity in CCl4-induced hepatotoxicity models in rats.

Evidence strength: Hepatoprotective evidence is exclusively from animal models and in vitro cell studies. No human clinical data are available.

4.5 Antimicrobial Activity

Phytochemical analysis of S. sesban bark revealed the presence of bioactive compounds such as carbohydrates, flavonoids, steroids, alkaloids, tannins, and saponins. In disc diffusion assays, chloroform (250 and 500 µg/ml) and ethanol (500 µg/ml) extracts exhibited broad-spectrum antibacterial activity against both Gram-positive and Gram-negative bacteria. The ethanol extract at 250 µg/ml and ether extracts showed slightly reduced activity, with limited ineffectiveness against Proteus vulgaris and Enterococcus faecalis.

Sesbania grandiflora has been shown to have a wide range of anti-microbial action, with anti-tubercular activity being quite remarkable. The leaf and flower extracts have been reported to have activity against various human pathogens, including Gram-positive Staphylococcus aureus, P. aeruginosa, and fish pathogens. A rather interesting discovery is that the plant could fight bacterial biofilms.

Antituberculosis: All of the isolated isoflavonoid compounds — isovestitol, medicarpin, sativan, and betulinic acid — exhibited antituberculosis activity against Mycobacterium tuberculosis H37Rv, with MIC values of 50 µg/mL for compounds 1–3 and 100 µg/mL for compound 4. This was the first report on the occurrence of isoflavonoids in this plant and their antituberculosis activity.

Evidence strength: All antimicrobial evidence is in vitro (disc diffusion, MIC assays). No human clinical antimicrobial trials have been reported.

4.6 Anthelmintic Activity

The leaf decoction of Sesbania sesban var. bicolor is used traditionally by the Santhal tribe of Assam, India, for the treatment of intestinal helminthic infections. A study was conducted to evaluate the in vitro and in vivo anthelmintic efficacy of methanolic extract of S. sesban var. bicolor leaves using Hymenolepis diminuta–rat (cestode) and Syphacia obvelata–mice (nematode) as test parasites and models. At the highest concentration of 30 mg/ml of the plant extract, H. diminuta and S. obvelata showed mortality at 0.81 ± 0.01 h and 15.17 ± 0.05 h, respectively. The in vivo results substantiated the in vitro findings, and the extract showed better cestocidal efficacy in a dose-dependent manner, whereby treatment of rats with 400 mg/kg of the plant extract caused a 65.10% reduction in eggs per gram (EPG) of faeces and 56% reduction in worm counts.

Evidence strength: Anthelmintic evidence comes from one PMC-indexed in vitro and in vivo animal study. No human trials have been published.

4.7 Spermicidal / Antifertility Activity

The spermicidal activity of oleanolic acid 3-β-D-glucuronide (OAG), an active principle isolated from root extracts of Sesbania sesban, was evaluated. Under the Sander-Cramer test criteria, the sperm-immobilizing activity of OAG was studied using highly motile rat sperm. Sperm mortality and membrane integrity were assessed by supravital staining, hypo-osmotic swelling (HOS), transmission electron microscopy (TEM), and sperm membrane lipid peroxidation (LPO). In vitro microbicidal potential and hemolytic index of OAG were examined in Lactobacillus culture and rat red blood corpuscles (RBCs). Post-intravaginal OAG application, the in vivo contraceptive efficacy was evaluated in rats. The Ames test determined the carcinogenic potential of OAG. The minimum effective concentration (MEC) of OAG was 50 mcg/mL. More than 97% of the OAG-treated sperm lost their HOS responsiveness in a dose-dependent manner.

Evidence strength: Spermicidal and antifertility evidence is from in vitro and animal studies. No human contraceptive trials have been reported.

4.8 Cytotoxic / Anticancer Activity

These species, known for their diverse phytochemical compositions, exhibit notable cytotoxic effects that suggest their utility in natural cancer treatments. Compounds such as quercetin, kaempferol, and sesbagrandiforian A and B have been highlighted for their strong antioxidant and antiproliferative effects.

Sesbania grandiflora has transitioned from a traditional remedy to a scientifically recognized source of diverse bioactive compounds, including flavonoids, terpenoids, phenolics, 2-arylbenzofurans, and cytotoxic peptides. Modern research confirms its multitarget, multicomponent synergy as the basis for its potent anticancer, antidiabetic, anti-inflammatory, and antimicrobial effects.

Evidence strength: Anticancer evidence is based entirely on in vitro cytotoxicity assays and in vivo animal models. No human oncology clinical trials have been reported.

4.9 Wound Healing

One study evaluated wound healing activity of ethanolic extract of leaves in rabbits using an excision wound model in the form of ointment using concentrations of 2 and 4% w/w in simple ointment base. Additional preclinical studies examined the methanolic extract of bark in Wistar albino rat wound models.

Evidence strength: All wound-healing evidence is from preclinical animal models. No human clinical trials have been reported.

4.10 Hypolipidemic Activity

In a more recent investigation, S. grandiflora leaf supplementation was demonstrated to have a significant hypolipidemic impact against Triton-induced hyperlipidemia in rats. In the antidiabetic study, methanolic extract of S. grandiflora also restored lipid parameters in addition to glycemic markers.

Evidence strength: Hypolipidemic evidence is from animal models only.

5. Body Systems and Health Areas Associated with Sesbania

• Endocrine / Metabolic System: Blood glucose regulation, insulin sensitivity, HbA1C normalization, lipid profile improvement (animal studies).
• Hepatic System: Protection against chemically induced hepatotoxicity; restoration of liver enzyme markers and antioxidant capacity (animal studies).
• Immune and Inflammatory System: Anti-inflammatory and anti-arthritic effects in adjuvant-induced arthritis models; saponin-mediated topical anti-inflammatory activity.
• Antimicrobial / Infectious Disease: Broad-spectrum antibacterial activity in vitro; antituberculosis activity of isolated isoflavonoids; anthelmintic efficacy against tapeworms and roundworms in animal models.
• Cardiovascular System: The plant was studied for cardioprotective activity against cigarette smoke-induced oxidative damage in rats treated with S. grandiflora aqueous extract at 1000 mg/kg body weight per day orally for 3 weeks. The plant appears to protect the heart from oxidative damage through its antioxidant potential.
• Respiratory System: Traditional use for asthma, bronchitis, and cough; expectorant properties documented in traditional systems.
• Oncological: In vitro cytotoxicity and antiproliferative activity; caspase cascade activation and apoptosis induction in cancer cell lines (all preclinical).
• Reproductive System: Spermicidal and antifertility activity attributed to OAG (animal and in vitro studies).
• Gastrointestinal System: Traditional use as a purgative, demulcent, anthelmintic; antiulcer activity reported in preclinical studies.
• Nervous System: Nootropic and neuroprotective activity in streptozotocin-induced diabetic model rats has been investigated.

6. Dosage Forms and Dosages Reported in Studies

Dosages below are reported exactly as stated in cited peer-reviewed sources and refer exclusively to experimental (animal) models unless otherwise noted:

• Antidiabetic — S. grandiflora methanolic leaf extract (MESG): 200 and 400 mg/kg orally, compared to metformin 10 mg/kg, for 28 days.
• Antidiabetic — S. grandiflora flower extract (SGF): 250 mg/kg body weight for 45 days.
• Antidiabetic — S. sesban aqueous leaf extract: 250 and 500 mg/kg body weight per day for 30 days, compared to glibenclamide (0.25 mg/kg).
• Hepatoprotective — S. grandiflora ethanolic leaf extract: 200 mg/kg/day for 15 days.
• Hepatoprotective — S. grandiflora flower extract (CCl4 model): 200 mg/kg body weight.
• Cardioprotective — S. grandiflora aqueous extract: 1000 mg/kg body weight per day orally for 3 weeks.
• Anthelmintic — S. sesban var. bicolor methanolic leaf extract (in vitro): Highest concentration tested was 30 mg/ml.
• Anthelmintic — in vivo: 400 mg/kg of plant extract caused 65.10% reduction in EPG and 56% reduction in worm counts.
• Spermicidal — OAG isolated from S. sesban roots: Minimum effective concentration (MEC) of OAG was 50 mcg/mL.
• Anti-inflammatory — saponin crude extract from S. sesban leaves: Tested topically in preclinical models.
• Antituberculosis — isolated isoflavonoids from S. grandiflora root: MIC values of 50 µg/mL for isovestitol, medicarpin, and sativan; 100 µg/mL for betulinic acid, against M. tuberculosis H37Rv.

In terms of prepared dosage forms, the various plant parts are used in different forms such as paste, cream, powder, tablets, capsules, tincture, extracts, and tonic. No standardized human dosing has been established in peer-reviewed literature.

7. Safety Considerations and Known Interactions

Preclinical Toxicity Data

One investigation analyzed the negative consequences of short- and long-term administration of a hydroalcoholic extract of S. grandiflora leaf in experimental animals. The study involved two phases: acute toxicity performed at 2,000 mg/kg, with adverse effects recorded; and sub-acute toxicity with different doses of 1,000, 2,000, and 5,000 mg/kg studied for 28 days. The results of the above research revealed that orally administered S. grandiflora extract did not exhibit any apparent harmful effects in experimental animals and could be regarded as safe and used for therapeutic purposes in human beings.

A systematic review reported that most studies characterize Sesbania sesban as having great anti-microbial, anti-fungal, anti-inflammatory, and anti-diabetic qualities. No study in the review reported any adverse effect of the plant. The same systematic review recommended a dose-effect assessment and mechanism studies before clinical translation.

Spermicidal / Reproductive Safety

In vitro microbicidal potential and hemolytic index of OAG were examined in Lactobacillus culture and rat red blood corpuscles. Post-intravaginal OAG application, the in vivo contraceptive efficacy was evaluated in rats. The Ames test determined the carcinogenic potential of OAG. While OAG demonstrated spermicidal potential, this also signals a relevant consideration regarding reproductive safety: the compound's activity as an antifertility agent means that applications in people seeking conception would be contraindicated based on these preclinical findings. The antifertility effect of these triterpene acids is attributed to their antiestrogenic activity, which may be responsible for arresting spermatogenesis in tested animal models.

Pharmacokinetic Gaps

Human clinical trials are scarce. Pharmacokinetic data for many of the major compounds are lacking, and the poor bioavailability of specific lipophilic actives emphasizes the importance of advanced delivery systems.

Evidence Quality Limitations

Authors recommend a dose-effect assessment and mechanism studies before clinical conclusions can be drawn. The entire pharmacological body of evidence for Sesbania spp. resides overwhelmingly in in vitro experiments and rodent models, with essentially no registered, peer-reviewed randomized controlled trials in humans. The absence of standardized extracts, defined active-compound ratios, and human pharmacokinetic data means that safety and efficacy in humans remain uncharacterized by clinical standards.

References

• PMC11768378 — Distribution, Phytochemical Insights, and Cytotoxic Potential of the Sesbania Genus: A Comprehensive Review (PMC, 2025)
• PMC10807938 — Medicinal and Ethnomedicinal Uses, Biological Features, and Phytochemical Constituents of Sesbania sesban, Republic of Chad (PMC, 2024)
• PMC4893447 — Extract of Sesbania grandiflora Ameliorates Hyperglycemia in High Fat Diet-Streptozotocin Induced Experimental Diabetes Mellitus (PMC, 2016)
• PMC8241611 — Ameliorative property of Sesbania grandiflora on carbohydrate metabolic enzymes in the liver and kidney of streptozotocin-induced diabetic rats (PMC, 2021)
• PMC3558175 — Antidiabetic Activity of Aqueous Leaves Extract of Sesbania sesban (L) Merr. in Streptozotocin Induced Diabetic Rats (Avicenna J Med Biotechnol, 2011)
• PMC3763669 — The Chemical Components of Sesbania grandiflora Root and Their Antituberculosis Activity (PMC, 2013)
• PMC7921245 — In vitro and in vivo anthelmintic study of Sesbania sesban var. bicolor (PMC, 2021)
• PMC11408849 — Hepatoprotective effect of flavonoid rich fraction of Sesbania grandiflora: In vivo, in vitro, and molecular docking studies (PMC, 2024)
• PubMed 21237343 — Potent spermicidal effect of oleanolic acid 3-beta-D-glucuronide, an active principle isolated from Sesbania sesban (Contraception, 2011)
• Journal of Applied Pharmaceutical Sciences — Sesbania grandiflora (L.) Pers.: A review of its phytochemistry, molecular pharmacology, and clinical potential (2026)
• International Journal of Research in Medical Sciences — Pharmacological effects of Sesbania sesban: a systematic review (2020)
• Asian Journal of Biomedical and Pharmaceutical Sciences — Sesbania sesban Linn: A Review on Its Ethnobotany, Phytochemical and Pharmacological Profile (2012)
• Wikipedia — Sesbania (genus overview)
• Wikipedia — Sesbania sesban
• Plants of the World Online (Kew Science) — Sesbania sesban (L.) Merr.
• GBIF Backbone Taxonomy — Sesbania Scop.
• Vegetos / Springer — A comprehensive review of Sesbania grandiflora (L.) Pers: traditional uses, phytochemistry and pharmacological properties (2023)
• The Scientific World Journal / Wiley — Medicinal and Ethnomedicinal Uses of Sesbania sesban, Republic of Chad (2024)
• IJSDR — A Review on Sesbania sesban: Botanical, Phytochemical, and Pharmacological (2026)
• Semantic Scholar — Evaluation of toxicity studies of Sesbania grandiflora leaves extracts in Wistar albino rats